Zhang Yizhou, Chen Qichen, Chen Xiao, Zhang Mingzhu, Li Peng, Huang Zhen, Zhao Hong, Wu Hongliang
Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China.
J Cancer. 2022 Aug 29;13(11):3189-3198. doi: 10.7150/jca.74674. eCollection 2022.
No previous studies have reported the effect of intraoperative opioid consumption in colorectal liver metastasis (CRLM). Medical records of patients who received simultaneous resection of CRLM were retrospectively reviewed. Patients with epidural anesthesia, intraoperative morphine, or intraoperative oxycodone were excluded. Patients were separated into high- and low-dose groups by median intraoperative equianalgesic fentanyl dose. Short-term outcomes, progression-free surcical (PFS) and overall survival (OS) were compared between groups before and after 1:1 propensity score matching (PSM). Univariable and multivariable Cox regression analysis were performed to identify independent predictors of survival. The final study population included 343 patients. Patients were separated into the low dose group (n=172) and the high dose group (n=171) by median intraoperative equianalgesic fentanyl dose (8.33 μg/kg). After PSM, 55 patients in the low dose group were matched to 55 patients in the high dose group and the baseline characteristics of the two groups were balanced. The two groups had no statistically significance difference in severity and categories of postoperative complications before and after PSM. Before PSM, the two groups had similar PFS (median 10.2 vs. 12.4 months, =0.54) and OS (median 59.0 vs. 58.3 months, =0.76). Univariate and multivariate Cox regression analyses revealed no statistically significant association between intraoperative equianalgesic fentanyl and PFS (multivariate HR=0.852, 95% CI 0.655-1.11, =0.235) and OS (multivariate HR=1, 95% CI 0.68-1.49, = 0.981). After PSM, the two groups also had similar PFS (median 9.2 vs. 10.7 months, =0.98) and OS (median 51.0 vs. 46.0 months, =0.39). Univariate and multivariate Cox regression analyses revealed no statistically significant association between intraoperative equianalgesic fentanyl and PFS (multivariate HR=1.05, 95% CI 0.632-1.73, =0.861) and OS (multivariate HR=1.74, 95% CI 0.892-3.38, = 0.105). Intraoperative opioids consumption was not correlated with outcomes of CRLM patients treated with simultaneous resection.
此前尚无研究报告术中阿片类药物用量对结直肠癌肝转移(CRLM)患者的影响。我们回顾性分析了接受CRLM同期切除患者的病历。排除接受硬膜外麻醉、术中使用吗啡或羟考酮的患者。根据术中芬太尼等效镇痛剂量的中位数将患者分为高剂量组和低剂量组。在1:1倾向评分匹配(PSM)前后,比较两组患者的短期预后、无进展生存期(PFS)和总生存期(OS)。进行单因素和多因素Cox回归分析以确定生存的独立预测因素。最终研究人群包括343例患者。根据术中芬太尼等效镇痛剂量中位数(8.33μg/kg),将患者分为低剂量组(n = 172)和高剂量组(n = 171)。PSM后,低剂量组的55例患者与高剂量组的55例患者匹配,两组的基线特征达到平衡。PSM前后,两组术后并发症的严重程度和类别无统计学差异。PSM前,两组的PFS(中位数10.2个月对12.4个月,P = 0.54)和OS(中位数59.0个月对58.3个月,P = 0.76)相似。单因素和多因素Cox回归分析显示,术中芬太尼等效镇痛剂量与PFS(多因素HR = 0.852,95%CI 0.655 - 1.11,P = 0.235)和OS(多因素HR = 1,95%CI 0.68 - 1.49,P = 0.981)之间无统计学显著关联。PSM后,两组的PFS(中位数9.2个月对10.7个月,P = 0.98)和OS(中位数51.0个月对46.0个月,P = 0.39)也相似。单因素和多因素Cox回归分析显示,术中芬太尼等效镇痛剂量与PFS(多因素HR = 1.05,95%CI 0.632 - 1.73,P = 0.861)和OS(多因素HR = 1.74,95%CI 0.892 - 3.38,P = 0.105)之间无统计学显著关联。术中阿片类药物用量与接受同期切除的CRLM患者的预后无关。